About This Research

Researchers are seeking 20 people in the U.S. with relapsing forms of Multiple Sclerosis including clinically isolated syndrome (CIS), relapsing-remitting multiple sclerosis (RRMS), and active secondary progressive disease (SPMS) to participate in a 1-hour telephone/online interview. The purpose of the interview is to gain insights from people who are taking or have recently taken Vumerity® about the impacts of the treatment on their quality of life.

To participate in this interview, you must have taken Vumerity® for at least 5 weeks within the past 6 months; you may currently be taking Vumerity® or you may have discontinued Vumerity® within the past 6 months.
During the interview, you will be asked questions by a moderator and you will be required to use your computer or other suitable mobile device to view information being shared by the moderator. Your interview will be recorded; however, your identity will remain anonymous. Interviews will be scheduled at a time most convenient for you. Participation is strictly voluntary.

To participate in these interviews, eligible participants must:
  • have taken Vumerity® for at least 5 weeks during the past 6 months
  • be 18 years of age, or older
  • provide informed consent
If your answers here indicate that this interview is a good match for you, we will contact you via email to gain your consent to participate in this research, and once you have provided your consent we will schedule a time for your interview.

All participants who complete the 1-hour interview will be compensated with a $150 Amazon eCertificate.
  • Your information will only be used for market research and will not be passed to any other organization without your permission.  We need your consent in order for us to collect and use any information about you.
  • You have the right to refuse to answer questions or withdraw at any time.  For more information about your rights and data retention period, please see our privacy policy at http://www.kantarhealth.com/privacy-policy.
  • You will not be asked to purchase anything for participating in this survey.  

For questions regarding this opportunity, please email research@endeavour-clinical.com.
 
33% of survey complete.

T